HP Total Cost of Revenue decreased by 0.6% to $11.60B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.8%, from $10.66B to $11.60B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows a downward trend with a -3.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $12.44B | $11.90B | $13.39B | $13.62B | $13.18B | $11.76B | $12.08B | $11.01B | $9.99B | $10.37B | $10.83B | $10.30B | $9.78B | $10.61B | $11.05B | $10.66B | $10.48B | $11.08B | $11.68B | $11.60B |
| QoQ Change | — | -4.3% | +12.5% | +1.7% | -3.3% | -10.7% | +2.7% | -8.9% | -9.2% | +3.8% | +4.4% | -4.9% | -5.1% | +8.6% | +4.2% | -3.5% | -1.7% | +5.7% | +5.4% | -0.6% |
| YoY Change | — | — | — | — | +6.0% | -1.2% | -9.8% | -19.2% | -24.2% | -11.8% | -10.4% | -6.5% | -2.2% | +2.3% | +2.0% | +3.6% | +7.2% | +4.4% | +5.6% | +8.8% |